View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, April 28 (HealthDay News) -- The U.S. Food and Drug Administration has issued a warning about external defibrillators manufactured by Cardiac Science Corp. that may malfunction when being used to rescue people in cardiac arrest.
About 280,000 defibrillators, used internationally in homes, public settings and health care facilities, have faulty components that may result in the devices failing to properly deliver the shock needed to restore normal heart rhythm in the event of sudden cardiac arrest, according to the FDA. The affected models may also have problems with interruption of electrocardiography analysis, failure to recognize electrode pads, and interference that makes the device unable to analyze heart rhythm accurately.
The 14 affected models are the Powerheart models 9300A, 9300C, 9300D, 9300E, 9300P, 9390A and 9390E; the CardioVive models 92531, 92532 and 92533; the Nihon Kohden models 9200G and 9231; and the GE Responder models 2019198 and 2023440. The FDA recommends that those with faulty models obtain alternative defibrillators and arrange for replacement or repair of the affected models.
"The FDA is issuing this notice so that users can take the proper steps necessary to assure they have access to safe and effective defibrillators," Jeffrey Shuren, M.D., director of the FDA's Center for Devices and Radiological Health, said in a statement.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top